New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Wu, Chengxiang ^a,b   Nerurkar, Vivek R ^a   Lu, Yuanan ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b NONE   (United States)

Author keywords

HIV 1 inhibition; Mutant tRNALys3; Reverse transcription

Indexed keywords

LYSINE TRANSFER RNA; MUTANT PROTEIN; RETROVIRUS VECTOR;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG SYNTHESIS; ENVELOPE GENE; GENE CASSETTE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REVERSE TRANSCRIPTION; TARGET CELL; TRANSCRIPTION INITIATION; TRNALYS3 GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

HIV-1; HUMANS; MUTATION; REVERSE TRANSCRIPTION; RNA, COMPLEMENTARY; RNA, TRANSFER, LYS; VIRUS REPLICATION;

EID: 84886002897     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-112     Document Type: Article

References (65)

1. Zhang H, Dornadula G, Pomerantz RJ. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J Virol 1996, 70(5):2809-2824. 190138, 8627755.
2. Mougel M, Houzet L, Darlix JL. When is it time for reverse transcription to start and go?. Retrovirology 2009, 6:24. 10.1186/1742-4690-6-24, 2656454, 19261185.
3. Harada F, Peters GG, Dahlberg JE. The primer tRNA for moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro. J Biol Chem 1979, 254:10979-10985.
4. Harada F, Sawyer RC, Dahlberg JE. A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis. J Biol Chem 1975, 250:3487-3497.
5. Litvak S, Araya A. Primer transfer RNA in retroviruses. Trends Biochem Sci 1982, 7:361-364.
6. Leis J, Aiyar A, Cobrinik D. Regulation of initiation of reverse transcription of retroviruses. Reverse transcriptase 1993, 33-48. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, Skalka AM, Goff SP.
7. Marquet R, Isel C, Ehresmann C, Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie 1995, 77:113-124. 10.1016/0300-9084(96)88114-4, 7541250.
8. Mak J, Kleiman L. Primer tRNAs for reverse transcription. J Virol 1997, 71:8087-8095. 192263, 9343157.
9. Telesnitsky A, Goff SP. Reverse transcriptase and the generation of retroviral DNA. Retroviruses 1997, 121-160. Plainview, NY: Cold Spring Harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
10. Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 1985, 40:9-17. 10.1016/0092-8674(85)90303-4, 2981635.
11. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987, 326:662-669. 10.1038/326662a0, 3031510.
12. Goff SP. Retroviral reverse transcriptase: synthesis, structure, and function. J Acquir Immune Defic Syndr 1990, 3:817-831.
13. Ben Artzi H, Shemesh J, Zeelon E, Amit B, Kleiman L, Gorecki M, Panet A. Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry 1996, 35:10549-10557. 10.1021/bi960439x, 8756711.
14. Auxilien S, Keith G, Le Grice SFJ, Darlix JL. Role of post-transcriptional modifications of primer tRNALys3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J Biol Chem 1999, 274:4412-4420. 10.1074/jbc.274.7.4412, 9933645.
15. Allain B, Lapadat-Tapolsky M, Berlioz C, Darlix J-LL. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J 1994, 13(4):973-981. 394899, 7509280.
16. Tsuchihashi Z, Brown PO. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J Virol 1994, 68(9):5863-5870. 236991, 8057466.
17. Guo J, Henderson LE, Bess J, Kane B, Levin JG. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J Virol 1997, 71(7):5178-5188. 191753, 9188585.
18. Guo J, Wu T, Anderson J, Kane BF, Johnson DG, Gorelick RJ, Henderson LE, Levin JG. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J Virol 2000, 74(19):8980-8988. 10.1128/JVI.74.19.8980-8988.2000, 102094, 10982342.
19. Yu Q, Darlix J-L. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. J Virol 1996, 70(9):5791-5798. 190593, 8709195.
20. Gonsky J, Bacharach E, Goff SP. Identification of residues of the moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. J Virol 2001, 75(6):2616-2626. 10.1128/JVI.75.6.2616-2626.2001, 115885, 11222684.
21. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques BP. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol 1995, 254(4):523-537. 10.1006/jmbi.1995.0635, 7500330.
22. Li X, Mak J, Arts EJ, Gu Z, Kleiman L, Wainberg MA, Parniak MA. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol 1994, 68:6198-6206. 237039, 7521916.
23. Das AT, Klaver B, Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol 1995, 69:3090-3097. 189010, 7707537.
24. Wakefield JK, Wolf AG, Morrow CD. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNALys3. J Virol 1995, 69:6021-6029. 189498, 7545240.
25. Das AT, Klaver B, Berkhout B. Sequence variation of the HIV primer-binding site suggests the use of an alternative tRNALys3 molecule in reverse transcription. J Gen Virol 1997, 78:837-840.
26. Das AT, Vink M, Berkhout B. Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity. J Virol 2005, 79:3179-3181. 10.1128/JVI.79.5.3179-3181.2005, 548477, 15709038.
27. Schwartzberg P, Colicelli J, Goff SP. Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair. J Virol 1985, 53:719-726. 254699, 2983084.
28. Colicelli J, Goff SP. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol 1986, 57:37-45. 252696, 2416955.
29. Lund AH, Duch M, Lovmand J, Jorgensen P, Pedersen FS. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol 1993, 67:7125-7130. 238174, 7693968.
30. Abbink TE, Beerens N, Berkhout B. Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme. J Virol 2004, 78(19):10706-10714. 10.1128/JVI.78.19.10706-10714.2004, 516392, 15367637.
31. Renda MJ, Bradel-Tretheway B, Planelles V, Bambara RA, Dewhurst S. Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3)A58U. AIDS Res Hum Retroviruses 2004, 20:1324-1334. 10.1089/aid.2004.20.1324, 15650425.
32. Renda MJ, Rosenblatt JD, Klimatcheva E, Demeter LM, Bambara RA, Planelles V. Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol 2001, 75:9671-9678. 10.1128/JVI.75.20.9671-9678.2001, 114538, 11559799.
33. Lu Y, Planelles V, Li X, Palaniappan C, Day B, Challita-Eid P, Amado R, Stephens D, Kohn DB, Bakker A, Fay P, Bambara RA, Rosenblatt JD. Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem 1997, 272:14523-14531. 10.1074/jbc.272.23.14523, 9169409.
34. Wu C, Lu Y. High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages. J Gen Virol 2010, 91:1909-1918. 10.1099/vir.0.020255-0, 3052536, 20410313.
35. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989, 86(10):3519-3523. 10.1073/pnas.86.10.3519, 287169, 2542934.
36. Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J Virol 1987, 61(5):1647-1650. 254147, 3033290.
37. Baldwin TO. Firefly luciferase: the structure is known, but the mystery remains. Structure 1996, 4(3):223-228. 10.1016/S0969-2126(96)00026-3, 8805542.
38. Cao S, Wu C, Yang Y, Sniderhan LF, Maggirwar SB, Dewhurst S, Lu Y. Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for NeuroAIDS. J Neuroinflammation 2011, 8:48. 10.1186/1742-2094-8-48, 3118348, 21569583.
39. Altman S. Transfer RNA processing enzymes. Cell 1981, 23(1):3-4. 10.1016/0092-8674(81)90262-2, 7011569.
40. Sampson JR, DiRenzo AB, Behlen LS, Uhlenbeck OC. Role of the tertiary nucleotides in the interaction of yeast phenylalanine tRNA with its cognate synthetase. Biochemistry 1990, 29:2523-2532. 10.1021/bi00462a014, 2334680.
41. Behlen LS, Sampson JR, DiRenzo AB, Uhlenbeck OC. Lead-catalyzed cleavage of yeast tRNAPhe mutants. Biochemistry 1990, 29:2515-2523. 10.1021/bi00462a013, 2334679.
42. Waters LC, Mullin BC. Transfer RNA in RNA tumor viruses. Prog Nucleic Acid Res Mol Biol 1977, 20:131-160.
43. Jiang M, Mak J, Wainberg MA, Parniak MA, Cohen E, Kleiman L. Variable tRNA content in HIV-1IIIB. Biochem Biophys Res Commun 1992, 185:1005-1015. 10.1016/0006-291X(92)91727-8, 1627125.
44. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, Kleiman L. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 1993, 67:3246-3253. 237665, 8497049.
45. Mak J, Jiang M, Wainberg MA, Hammarskjold ML, Rekosh D, Kleiman L. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J Virol 1994, 68:2065-2072. 236680, 7511167.
46. Peters GG, Hu J. Reverse transcriptase as the major determinant for selective packaging of tRNA's into avian sarcoma virus particles. J Virol 1980, 36:692-700. 353697, 6162035.
47. Levin JG, Seidman JG. Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly. J Virol 1981, 38:403-408. 171167, 6165833.
48. Khorchid A, Javannbakht H, Wise S, Halwani R, Parniak MA, Wainberg MA, Kleiman L. Sequences within Pr160gag-pol affecting the selective packaging of primer tRNALys3 into HIV-1. J Mol Biol 2000, 299:17-26. 10.1006/jmbi.2000.3709, 10860720.
49. Huang Y, Mak J, Cao Q, Li Z, Wainberg MA, Kleiman L. Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1. J Virol 1994, 68:7676-7683. 237227, 7966556.
50. Jiang M, Mak J, Huang Y, Kleiman L. Reverse transcriptase is an important factor for the primer tRNA selection in HIV-1. Leukemia 1994, 8:149-151.
51. Cen S, Javanbakht H, Kim S, Shiba K, Craven R, Rein A, Ewalt K, Schimmel P, Musier-Forsyth K, Kleiman L. Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J Virol 2002, 76:13111-13115. 10.1128/JVI.76.24.13111-13115.2002, 136713, 12438642.
52. Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem 2003, 278:27644-27651. 10.1074/jbc.M301840200, 12756246.
53. Gabor J, Cen S, Javanbakht H, Niu M, Kleiman L. Effect of altering the tRNA concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, Gag-Pol incorporation, and viral infectivity. J Virol 2002, 76:9096-9102. 10.1128/JVI.76.18.9096-9102.2002, 136429, 12186893.
54. Guo F, Cen S, Niu M, Javanbakht H, Kleiman L. Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1. J Virol 2003, 77:9817-9822. 10.1128/JVI.77.18.9817-9822.2003, 224598, 12941890.
55. Cen S, Javanbakht H, Niu M, Kleiman L. Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1. J Virol 2004, 78:1595-1601. 10.1128/JVI.78.3.1595-1601.2004, 321381, 14722314.
56. Halwani R, Cen S, Javanbakht H, Saadatmand J, Kim S, Shiba K, Kleiman L. Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly. J Virol 2004, 78:7553-7564. 10.1128/JVI.78.14.7553-7564.2004, 434110, 15220430.
57. Roy KL, Cooke H, Buckland R. Nucleotide sequence of a segment of human DNA containing the three tRNA genes. Nucleic Acids Res 1982, 10:7313-7322. 10.1093/nar/10.22.7313, 327006, 6296772.
58. Zeng L, Planelles V, Sui Z, Gartner S, Maggirwar SB, Dewhurst S, Ye L, Nerurkar VR, Yanagihara R, Lu Y. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med 2006, 8(1):18-28. 10.1002/jgm.825, 2825118, 16142830.
59. Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, Xia P, Malik P. Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3′LTR. Mol Ther 2009, 17(9):1527-1536. 10.1038/mt.2009.89, 2835256, 19384292.
60. ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008, 16(3):557-564. 10.1038/sj.mt.6300382, 18180777.
61. Wu C, Nerurkar VR, Yanagihara R, Lu Y. Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors. J Virol Methods 2008, 153(2):120-128. 10.1016/j.jviromet.2008.07.024, 2849798, 18755219.
62. Wu C, Lu Y. Inclusion of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency. Cell Mol Biol (Noisy-le-grand) 2007, 53:67-74.
63. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159.
64. Jeffrey ME, Armstrong LS, Martinez AO. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. Methods Cell Sci 1988, 11:15-17.
65. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996, 6:986-994. 10.1101/gr.6.10.986, 8908518.